James River Group Holdings, Ltd. Announces First Quarter Results
May 03, 2017 20:06 pm UTC| Business
FIRST QUARTER 2017 NET INCOME OF $18.5 MILLION -- $0.61 PER DILUTED SHARE, AND ADJUSTED NET OPERATING INCOME OF $17.7 MILLION -- $0.58 PER DILUTED SHARE EARNINGS PER DILUTED SHARE INCREASED OVER 40% COMPARED TO THE FIRST...
The Habit Restaurants, Inc. Announces First Quarter 2017 Financial Results
May 03, 2017 20:06 pm UTC| Business
IRVINE, Calif., May 03, 2017 -- The Habit Restaurants, Inc. (NASDAQ:HABT) (“The Habit” or the “Company”), today announced financial results for its first quarter ended March 28, 2017. Highlights for the first quarter...
The Habit Restaurants, Inc. Announces First Quarter 2017 Financial Results
May 03, 2017 20:06 pm UTC| Business
IRVINE, Calif., May 03, 2017 -- The Habit Restaurants, Inc. (NASDAQ:HABT) (“The Habit” or the “Company”), today announced financial results for its first quarter ended March 28, 2017. Highlights for the first quarter...
Arbor Realty Trust Declares Preferred Stock Dividends
May 03, 2017 20:05 pm UTC| Business
UNIONDALE, N.Y., May 03, 2017 -- Arbor Realty Trust, Inc. (NYSE:ABR), today announced that its Board of Directors has declared cash dividends on the Company’s Series A, Series B and Series C cumulative redeemable...
Green Bancorp, Inc. to Present at the 2017 Gulf South Bank Conference
May 03, 2017 20:05 pm UTC| Business
HOUSTON, May 03, 2017 -- Green Bancorp, Inc. (NASDAQ:GNBC), the bank holding company that operates Green Bank, N.A., today announced that Geoff Greenwade, President of Green Bancorp and CEO of Green Bank, Terry Earley,...
TRACON to Report First Quarter Company Highlights and Financial Results on May 10, 2017
May 03, 2017 20:05 pm UTC| Business
SAN DIEGO, May 03, 2017 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
May 03, 2017 20:05 pm UTC| Business
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., May 03, 2017 -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes